BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
4.060
+0.030 (0.74%)
Apr 28, 2026, 4:00 PM EDT - Market closed
BriaCell Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is August - July.
Millions USD. Fiscal year is Aug - Jul.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 31, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 29.9 | 10.49 | 0.86 | 21.25 | 41.04 | 57.27 | Upgrade
|
| Short-Term Investments | - | 7.37 | - | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 29.9 | 17.87 | 0.86 | 21.25 | 41.04 | 57.27 | Upgrade
|
| Cash Growth | 496.44% | 1972.44% | -95.94% | -48.22% | -28.34% | 269412.38% | Upgrade
|
| Other Receivables | - | - | 0.74 | - | 0.02 | 0.01 | Upgrade
|
| Receivables | - | - | 0.74 | - | 0.02 | 0.01 | Upgrade
|
| Prepaid Expenses | 2.28 | 2.06 | 2.06 | 5.7 | 1.28 | 0.52 | Upgrade
|
| Total Current Assets | 32.18 | 19.93 | 3.65 | 26.95 | 42.35 | 57.8 | Upgrade
|
| Property, Plant & Equipment | 0.25 | 0.3 | 0.39 | - | - | - | Upgrade
|
| Long-Term Investments | 0.58 | 0.52 | 0.42 | 0 | 0 | 0 | Upgrade
|
| Other Intangible Assets | 0.18 | 0.18 | 0.2 | 0.22 | 0.23 | 0.25 | Upgrade
|
| Other Long-Term Assets | 0.41 | 0.72 | 1.21 | - | - | - | Upgrade
|
| Total Assets | 33.59 | 21.65 | 5.87 | 27.16 | 42.58 | 58.04 | Upgrade
|
| Accounts Payable | 1.88 | 3.28 | 7.17 | 1.12 | 0.46 | 0.21 | Upgrade
|
| Accrued Expenses | 1.31 | 0.69 | 0.29 | 0.68 | 0.48 | 0.34 | Upgrade
|
| Total Current Liabilities | 3.19 | 3.98 | 7.46 | 1.8 | 0.94 | 0.56 | Upgrade
|
| Long-Term Debt | - | - | - | - | - | 0.03 | Upgrade
|
| Other Long-Term Liabilities | 0.2 | 0.34 | 1.1 | 29.14 | 31.31 | 29.79 | Upgrade
|
| Total Liabilities | 3.38 | 4.32 | 8.56 | 30.94 | 32.25 | 30.37 | Upgrade
|
| Common Stock | 117.12 | 101.74 | 72.17 | 69.59 | 65.59 | 54.77 | Upgrade
|
| Additional Paid-In Capital | - | - | - | - | - | 2.18 | Upgrade
|
| Retained Earnings | -127.17 | -111.76 | -85.44 | -80.65 | -60.35 | -29.14 | Upgrade
|
| Comprehensive Income & Other | 40.97 | 27.9 | 10.89 | 7.28 | 5.09 | -0.14 | Upgrade
|
| Total Common Equity | 30.92 | 17.88 | -2.38 | -3.78 | 10.33 | 27.67 | Upgrade
|
| Minority Interest | -0.7 | -0.55 | -0.3 | - | - | - | Upgrade
|
| Shareholders' Equity | 30.21 | 17.33 | -2.68 | -3.78 | 10.33 | 27.67 | Upgrade
|
| Total Liabilities & Equity | 33.59 | 21.65 | 5.87 | 27.16 | 42.58 | 58.04 | Upgrade
|
| Total Debt | - | - | - | - | - | 0.03 | Upgrade
|
| Net Cash (Debt) | 29.9 | 17.87 | 0.86 | 21.25 | 41.04 | 57.24 | Upgrade
|
| Net Cash Growth | 496.44% | 1972.44% | -95.94% | -48.22% | -28.30% | - | Upgrade
|
| Net Cash Per Share | 20.16 | 42.23 | 7.86 | 204.08 | 397.33 | 1899.79 | Upgrade
|
| Filing Date Shares Outstanding | 7.25 | 1.88 | 0.12 | 0.11 | 0.1 | 0.1 | Upgrade
|
| Total Common Shares Outstanding | 7.25 | 1.88 | 0.12 | 0.11 | 0.1 | 0.1 | Upgrade
|
| Working Capital | 28.99 | 15.95 | -3.81 | 25.15 | 41.41 | 57.24 | Upgrade
|
| Book Value Per Share | 4.26 | 9.49 | -19.54 | -35.45 | 99.84 | 271.83 | Upgrade
|
| Tangible Book Value | 30.74 | 17.7 | -2.58 | -3.99 | 10.1 | 27.43 | Upgrade
|
| Tangible Book Value Per Share | 4.24 | 9.39 | -21.18 | -37.47 | 97.61 | 269.42 | Upgrade
|
| Machinery | - | 0.46 | 0.46 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.